drugset / Trial / NCT06878417

Cannabinoids for Osteoarthritis Pain Effectiveness Trial

NCT06878417 ↗

RandomizedParallel-groupQuadruple-blindOther

Summary

This study aims to investigate whether oral cannabis extracts can effectively manage pain caused by osteoarthritis (OA), a common joint condition affecting one in seven Canadians. Current OA treatments often have limited effectiveness and may cause side effects. As a result, many individuals with OA turn to medical cannabis for pain relief, despite limited scientific evidence supporting its efficacy. The goal of this study is to assess the feasibility of a larger trial evaluating the effects of two cannabis compounds-CBD and THC-compared to a placebo (a look-alike substance containing no active drug) on pain interference in patients with hip and/or knee osteoarthritis. Participants will: * Take either CBD, THC, or a placebo capsule daily for 8 weeks * Complete follow-ups remotely, with no in-person clinic visits required * Maintain a diary tracking their study drug usage and any additional pain medications

Timeline

Start
2026-01-29
Primary completion
2026-12-31
Completion
2027-02-28

Drugs

EvaluationDrugModalityDoseRoute
Subject CBD Unknown — Oral
Subject THC Unknown — Oral